Sign In
Buy KPTI
$9.00
-0.230 (-2.49%)
At Close: Jun 03, 2026
Analysts Are Bullish on Top Healthcare Stocks: Aeglea Biotherapeutics (AGLE), uniQure (QURE)
11:07am, Thursday, 30'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aeglea Biotherapeutics (AGLE) and uniQure (QURE) with
Analysts Are Bullish on Top Healthcare Stocks: Aeglea Biotherapeutics (AGLE), uniQure (QURE)
11:07am, Thursday, 30'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aeglea Biotherapeutics (
AGLE
–
Research Report
) and uniQure (
QURE
–
Research Report
) with bulli
Emerald Advisers Inc Buys BellRing Brands Inc, Blueprint Medicines Corp, Science Applications ...
12:00am, Thursday, 30'th Apr 2020
- A Total of Five Abstracts Selected for Presentation, Including Two Highlighting Data from the Darzalex® and Kyprolis® Arms of the Phase 1b/2 STOMP Study - NEWTON, Mass.,.
Should You Buy Stock Now in This New Coronavirus Drug Developer?
11:47am, Wednesday, 29'th Apr 2020
Large and small drug developers and academic researchers are furiously testing and hoping to find one or more treatments for COVID-19. While novel drugs aimed specifically at the coronavirus could p
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:11am, Wednesday, 29'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Chimerix (CMRX) and Sarepta Therapeutics (SRPT) with
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:10am, Wednesday, 29'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Chimerix (CMRX
Karyopharm Announces Data from Phase ' BOSTON Study Selected for Late-Breaking Oral ...
12:00am, Wednesday, 29'th Apr 2020Karyopharm to Report First Quarter 2020 Financial Results on May 5, 2020
08:05pm, Tuesday, 28'th Apr 2020
-- Conference Call Scheduled for Tuesday, May 5, 2020, at 8:30 a.m. ET -- NEWTON, Mass., April 28, 2020 -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) today announced that it.
Charting a slow-motion breakout attempt, S&P 500 challenges major resistance (2,874)
04:42pm, Tuesday, 28'th Apr 2020
Technically speaking, the S&P 500’s jagged April recovery attempt remains in play amid still receding market volatility, writes Michael Ashbaugh.
H.C. Wainwright Thinks Spectrum Pharmaceuticals' Stock is Going to Recover
04:20pm, Tuesday, 28'th Apr 2020
In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on Spectrum Pharmaceuticals (SPPI), with a price target of $11.00.
H.C. Wainwright Thinks Spectrum Pharmaceuticals’ Stock is Going to Recover
04:20pm, Tuesday, 28'th Apr 2020
In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on Spectrum Pharmaceuticals (SPPI – Research
H.C. Wainwright Believes Syndax Pharmaceuticals (SNDX) Still Has Room to Grow
11:39am, Tuesday, 28'th Apr 2020
H.C. Wainwright analyst Edward White reiterated a Buy rating on Syndax Pharmaceuticals (SNDX) today and set a price target of $19.00. The company's shares
H.C. Wainwright Believes Syndax Pharmaceuticals (NASDAQ: SNDX) Still Has Room to Grow
11:39am, Tuesday, 28'th Apr 2020
H.C. Wainwright analyst
Edward White
reiterated a
Buy
rating on Syndax Pharmaceuticals (
SNDX
–
Research Report
) today and set a price target of
$19.00
. The company’s shares closed last Monday a
